BACKGROUND: There are currently no well-defined, evidence-based guidelines for management of end-stage heart failure in patients over 65, and the decisions to use mechanical circulatory support with left ventricular assist device (LVAD), either as a bridge to transplantation or destination therapy, or isolated heart transplantation (HTx) remain controversial. We aimed to compare the outcomes after the implementation of three heart replacement strategies in this high-risk population. METHODS: We conducted a retrospective cohort study of all patients between the ages of 65 and 72 receiving a continuous-flow LVAD as bridge to transplantation or destination therapy or isolated HTx at our center between 2005 and 2012. The patients were stratified according to treatment strategy into three groups: group D (destination LVAD, n = 23), group B (bridge to transplantation LVAD, n = 43), and group H (HTx alone, n = 47). The primary outcomes of interest were survival to discharge and 2-year overall survival. RESULTS: The patients in group D were significantly older, had a higher prevalence of ischemic cardiomyopathy, and had a higher pulmonary vascular resistance than did patients in groups B or H. There were no significant differences between groups in survival to discharge (87% D vs 83.7% B vs 87.2% H, p = 0.88) or 2-year overall survival (75.7% D vs 68.7% B vs 80.9% H, log-rank p = 0.47). The incidence rates of readmission were 1.1 events/patient·year in group D and 0.5 events/patient·year in group H. CONCLUSIONS: There was no significant difference in perioperative, short-term, and medium-term survival between the treatment groups. However, the LVAD patients had a higher incidence of readmission. Larger trials are needed to refine differences in long-term survival, quality of life, and resource utilization for elderly patients requiring heart replacement therapy.
BACKGROUND: There are currently no well-defined, evidence-based guidelines for management of end-stage heart failure in patients over 65, and the decisions to use mechanical circulatory support with left ventricular assist device (LVAD), either as a bridge to transplantation or destination therapy, or isolated heart transplantation (HTx) remain controversial. We aimed to compare the outcomes after the implementation of three heart replacement strategies in this high-risk population. METHODS: We conducted a retrospective cohort study of all patients between the ages of 65 and 72 receiving a continuous-flow LVADas bridge to transplantation or destination therapy or isolated HTx at our center between 2005 and 2012. The patients were stratified according to treatment strategy into three groups: group D (destination LVAD, n = 23), group B (bridge to transplantation LVAD, n = 43), and group H (HTx alone, n = 47). The primary outcomes of interest were survival to discharge and 2-year overall survival. RESULTS: The patients in group D were significantly older, had a higher prevalence of ischemic cardiomyopathy, and had a higher pulmonary vascular resistance than did patients in groups B or H. There were no significant differences between groups in survival to discharge (87% D vs 83.7% B vs 87.2% H, p = 0.88) or 2-year overall survival (75.7% D vs 68.7% B vs 80.9% H, log-rank p = 0.47). The incidence rates of readmission were 1.1 events/patient·year in group D and 0.5 events/patient·year in group H. CONCLUSIONS: There was no significant difference in perioperative, short-term, and medium-term survival between the treatment groups. However, the LVADpatients had a higher incidence of readmission. Larger trials are needed to refine differences in long-term survival, quality of life, and resource utilization for elderly patients requiring heart replacement therapy.
Authors: A M Borkon; G F Muehlebach; P G Jones; D R Bresnahan; R E Genton; M E Gorton; N D Long; A Magalski; C B Porter; W A Reed; S K Rowe Journal: J Heart Lung Transplant Date: 1999-07 Impact factor: 10.247
Authors: G Michael Felker; Carmelo A Milano; Jonathan E E Yager; Adrian F Hernandez; Laura Blue; Michael B Higginbotham; Andrew J Lodge; Stuart D Russell Journal: J Heart Lung Transplant Date: 2005-08-08 Impact factor: 10.247
Authors: Robert M Adamson; Marcia Stahovich; Suzanne Chillcott; Sam Baradarian; Joseph Chammas; Brian Jaski; Peter Hoagland; Walter Dembitsky Journal: J Am Coll Cardiol Date: 2011-06-21 Impact factor: 24.094
Authors: Matthew L Williams; Jaimin R Trivedi; Kelly C McCants; Sumanth D Prabhu; Emma J Birks; Laurie Oliver; Mark S Slaughter Journal: Ann Thorac Surg Date: 2011-03-24 Impact factor: 4.330
Authors: D Daneshvar; L S C Czer; A Phan; E R Schwarz; M De Robertis; J Mirocha; M Rafiei; J R Pixton; R M Kass; A Trento Journal: Transplant Proc Date: 2011-12 Impact factor: 1.066
Authors: R Favaloro; M Diez; A Bertolotti; C Gomez; L Favaloro; J Abud; C Nagel; C Vigliano; F Klein; S Perrone Journal: Transplant Proc Date: 2004 Jul-Aug Impact factor: 1.066
Authors: Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier Journal: N Engl J Med Date: 2009-11-17 Impact factor: 91.245
Authors: Mark J Russo; Ryan R Davies; Kimberly N Hong; Jonathan M Chen; Michael Argenziano; Alan Moskowitz; Deborah D Ascheim; Isaac George; Allan S Stewart; Mathew Williams; Annetine Gelijns; Yoshifumi Naka Journal: Ann Thorac Surg Date: 2009-04 Impact factor: 4.330
Authors: Sigrid E Sandner; Daniel Zimpfer; Philipp Zrunek; Angela Rajek; Heinrich Schima; Daniela Dunkler; Andreas O Zuckermann; Georg M Wieselthaler Journal: J Heart Lung Transplant Date: 2009-04 Impact factor: 10.247
Authors: Anuradha Lala; John C Rowland; Bart S Ferket; Annetine C Gelijns; Emilia Bagiella; Sean P Pinney; Alan J Moskowitz; Marissa A Miller; Francis D Pagani; Donna M Mancini Journal: JAMA Cardiol Date: 2020-06-01 Impact factor: 14.676
Authors: Christina A Theochari; George Michalopoulos; Evangelos K Oikonomou; Stefanos Giannopoulos; Ilias P Doulamis; M Alvarez Villela; Damianos G Kokkinidis Journal: Ann Cardiothorac Surg Date: 2018-01